Clinical Trial Results:
A Multicenter, Randomized, Double-Blind, Titration Study to
Evaluate and Compare the Efficacy and Safety of Ezetimibe 10
mg Added on to Rosuvastatin 5 mg, 10 mg, 20 mg, or 40 mg
Versus Up-Titration Rosuvastatin 10 mg, 20 mg, or 40 mg in Hypercholesterolemic
Patients at Moderately High and High Risk for
Coronary Heart Disease
Summary
|
|
EudraCT number |
2008-004953-14 |
Trial protocol |
HU FI DK |
Global completion date |
10 May 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
30 Mar 2016
|
First version publication date |
30 Mar 2016
|
Other versions |
|
Summary report(s) |
clinicaltrials.gov record including results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.